Zealand Pharma A/S (CPH:ZEAL)
437.40
-4.00 (-0.91%)
Aug 29, 2025, 4:59 PM CET
Zealand Pharma Revenue
Zealand Pharma had revenue of 9.09B DKK in the quarter ending June 30, 2025, with 26,527.65% growth. This brings the company's revenue in the last twelve months to 9.11B, up 2,375.69% year-over-year. In the year 2024, Zealand Pharma had annual revenue of 62.69M, down -81.71%.
Revenue (ttm)
9.11B
Revenue Growth
+2,375.69%
P/S Ratio
3.38
Revenue / Employee
21.49M
Employees
335
Market Cap
30.78B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.69M | -280.10M | -81.71% |
Dec 31, 2023 | 342.79M | 238.80M | 229.65% |
Dec 31, 2022 | 103.99M | -4.56M | -4.20% |
Dec 31, 2021 | 108.55M | -83.46M | -43.47% |
Dec 31, 2020 | 192.00M | 150.67M | 364.52% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 311.94B |
Coloplast | 27.87B |
Genmab | 23.16B |
Demant | 22.59B |
ALK-Abelló | 5.86B |
H. Lundbeck | 23.52B |
Ambu A/S | 5.96B |
Bavarian Nordic | 6.46B |
Zealand Pharma News
- 1 day ago - Zealand Pharma to participate in upcoming investor conferences in September 2025 - GlobeNewsWire
- 9 days ago - Zealand Pharma major shareholder announcement: Van Herk Investments B.V. - GlobeNewsWire
- 15 days ago - Zealand Pharma A/S (ZLDPF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Zealand Pharma reports 1H results - Seeking Alpha
- 16 days ago - Zealand Pharma Announces Financial Results for the First Half of 2025 - GlobeNewsWire
- 22 days ago - Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results - GlobeNewsWire
- 6 weeks ago - Zealand Pharma major shareholder announcement: Van Herk Investments B.V. - GlobeNewsWire
- 2 months ago - Zealand Pharma Obesity Therapy Shows Positive Trial Results - Market Watch